The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)butyl monophosphate ID: ALA574987
Chembl Id: CHEMBL574987
PubChem CID: 23263379
Max Phase: Preclinical
Molecular Formula: C8H13N2O6P
Molecular Weight: 264.17
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=c1ccn(CCCCOP(=O)(O)O)c(=O)[nH]1
Standard InChI: InChI=1S/C8H13N2O6P/c11-7-3-5-10(8(12)9-7)4-1-2-6-16-17(13,14)15/h3,5H,1-2,4,6H2,(H,9,11,12)(H2,13,14,15)
Standard InChI Key: GBNJFWXZTAZAOD-UHFFFAOYSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 264.17Molecular Weight (Monoisotopic): 264.0511AlogP: -0.57#Rotatable Bonds: 6Polar Surface Area: 121.62Molecular Species: ACIDHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 1.81CX Basic pKa: ┄CX LogP: -0.87CX LogD: -3.91Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.47Np Likeness Score: -0.20
References 1. Sauer R, El-Tayeb A, Kaulich M, Müller CE.. (2009) Synthesis of uracil nucleotide analogs with a modified, acyclic ribose moiety as P2Y(2) receptor antagonists., 17 (14): [PMID:19523835 ] [10.1016/j.bmc.2009.05.062 ]